Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA
Seventy percent of newly diagnosed bladder cancers are classified as non-muscle-invasive bladder cancer (NMIBC) and are often associated with high rates of recurrence that require lifelong surveillance. Currently available treatment options for NMIBC are associated with toxicities that limit their...
Main Authors: | Daniel A. Barocas, Denise R. Globe, Danielle C. Colayco, Ahunna Onyenwenyi, Amanda S. Bruno, Thomas J. Bramley, Rachel J. Spear |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2012/421709 |
Similar Items
-
Non muscle invasive bladder cancer: is active surveillance an option? our experience
by: M. Ennas, et al.
Published: (2020-10-01) -
Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
by: Zhu H, et al.
Published: (2019-05-01) -
Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
by: C. A. Chai, et al.
Published: (2021-05-01) -
Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity
by: Tang, Derek, et al.
Published: (2014) -
Active surveillance for nonmuscle invasive bladder cancer
by: Makito Miyake, et al.
Published: (2016-06-01)